Background/Aims: Biological and synthetic scaffolds play important roles in tissue engineering and are being developed towards human clinical applications. Based on previous work from our laboratory, we propose that extracellular matrices from skeletal muscle could be developed for adipose tissue engineering. Methods: Extracellular matrices (Myogels) extracted from skeletal muscle of various species were assessed using biochemical assays including ELISA and Western blotting. Biofunctionality was assessed using an in vitro differentiation assay and a tissue engineering construct model in the rat. Results: Myogels were successfully extracted from mice, rats, pigs and humans. Myogels contained significant levels of laminin α4- and α2-subunits and collagen I compared to Matrigel™, which contains laminin 1 (α1β1γ1) and collagen IV. Levels of growth factors such as fibroblast growth factor 2 were significantly higher than Matrigel, vascular endothelial growth factor-A levels were significantly lower and all other growth factors were comparable. Myogels reproducibly stimulated adipogenic differentiation of preadipocytes in vitro and the growth of adipose tissue in the rat. Conclusions: We found Myogel induces adipocyte differentiation in vitroand shows strong adipogenic potential in vivo, inducing the growth of well-vascularised adipose tissue. Myogel offers an alternative for current support scaffolds in adipose tissue engineering, allowing the scaling up of animal models towards clinical adipose tissue engineering applications.

Keywords:
Extracellular matrix, Muscle, Basement membrane, Adipogenesis
1.
Bachmeier, M., G. Loffler (1995) Influence of growth factors on growth and differentiation of 3T3-L1 preadipocytes in serum-free conditions. Eur J Cell Biol 68: 323–329.
2.
Badylak, S., J. Obermiller, L. Geddes, R. Matheny (2003) Extracellular matrix for myocardial repair. Heart Surg Forum 6: E20–E26.
3.
Bae, S.N., G. Arand, H. Azzam, P. Pavasant, J. Torri, T.L. Frandsen, E.W. Thompson (1993) Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24: 241–255.
4.
Barbosa, I., S. Garcia, V. Barbier-Chassefiere, J.-P. Caruelle, I. Martelly, D. Papy-Garcia (2003) Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13: 647–653.
5.
Beahm, E.K., R.L. Walton, C.W. Patrick Jr. (2003) Progress in adipose tissue construct development. Clin Plast Surg 30: 547–558.
6.
Behravesh, E., A.G. Mikos (2003) Three-dimensional culture of differentiating marrow stromal osteoblasts in biomimetic poly (propylene fumarate-co-ethylene glycol)-based macroporous hydrogels. J Biomed Mater Res A 66: 698–706.
7.
Bokhari, M.A., G. Akay, S. Zhang, M.A. Birch (2005) The enhancement of osteoblast growth and differentiation in vitro on a peptide hydrogel-polyHIPE polymer hybrid material. Biomaterials 26: 5198–5208.
8.
Boney, C.M., B.M. Moats-Staats, A.D. Stiles, A.J. D’Ercole (1994) Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 35: 1863–1868.
9.
Bradshaw, A.D., E.H. Sage (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049–1054.
10.
Bradshaw, A.D., D.C. Graves, K. Motamed, E.H. Sage (2003) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 100: 6045–6050
11.
Bryant, S.J., K.S. Anseth (2001) Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly (ethylene glycol) hydrogels. J Biomed Mater Res 59: 63–72.
12.
Burkhardt, D., S.Y. Hwa, P. Ghosh (2001) A novel microassay for the quantitation of the sulfated glycosaminoglycan content of histological sections: its application to determine the effects of Diacerhein on cartilage in an ovine model of osteoarthritis. Osteoarthritis Cartilage 9: 238–247.
13.
Cao, Y., P. Linden, D. Shima, F. Browne, J. Folkman (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor J Clin Invest 208: 2507–2511.
14.
Carbonetto, S.T., M.M. Gruver, D.C. Turner (1982) Nerve fiber growth on defined hydrogel substrates. Science 216: 897–899.
15.
Chen, T., H.D. Embree, E.M. Brown, M.M. Taylor, G.F. Payne (2003) Enzyme-catalyzed gel formation of gelatin and chitosan: potential for in situ applications. Biomaterials 23: 2831–2841.
16.
Cimini, M, D.R. Boughner, J.A. Ronald, D.E. Johnston, K.A. Rogers (2005) Dermal fibroblasts cultured on small intestinal submucosa: conditions for the formation of a neotissue. J Biomed Mater Res A 75: 895–906.
17.
Cinti, S, Cigolini M., M. Morroni, M.C. Zingaretti (1989) S-100 protein in white preadipocytes: an immunoelectronmicroscopic study. Anat Rec 224: 466–472.
18.
Colognato, H., P.D. Yurchenco (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218: 213–234.
19.
Crandall, D.L., G.J. Hausman, J.G. Kral (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211–232.
20.
Cronin, K.J., A. Messina, K.R. Knight, J.J. Cooper-White, G.W. Stevens, A.J. Penington, W.A. Morrison (2004) New murine model of spontaneous autologous tissue engineering combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg 113: 260–269.
21.
Darkovich, S.L., M. Brown-Etris, M. Spencer (1990) Biofilm hydrogel dressing: a clinical evaluation in the treatment of pressure sores. Ostomy Wound Manage 29: 47–60.
22.
Ding, L., I. Hennig, S.E. Evsyukov (2001) Non-ionic hydrogels by copolymerization of vinylene carbonate and oligo(ethylene glycol) vinyl ethers. Polymer 42: 2745–2753
23.
Distler, J.W., A. Hirth, M. Kurowska-Stolarska, R.E. Gay, S. Gay, O. Distler (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47: 149–161.
24.
Drury, J.L., D.J. Mooney (2003) Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24: 4337–4351.
25.
Eiselt, P., J. Yeh, R.K. Latvala, L.D. Shea, D.J. Mooney (2000) Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 21: 1921–1927.
26.
Eisenbud, D., H. Hunter, L. Kessler, K. Zulkowski (2003) Hydrogel wound dressings: where do we stand in 2003? Ostomy Wound Manage 49: 52–57.
27.
Farndale, R.W., D.J. Buttle, A.J. Barrett (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 882: 173–177.
28.
Gobin, A.S., J.L. West (2003) Effects of epidermal growth factor on fibroblast migration through biomimetic hydrogels Biotechnol Prog 19: 1781–1785.
29.
Gullberg, D., C.F. Tiger, T. Velling (1999) Laminins during muscle development and in muscular dystrophies. Cell Mol Life Sci 56: 442–460.
30.
Hagedorn, H.G., A.G. Nerlich (2000) Microvessel density and endothelial basement membrane composition in laryngeal squamous cell carcinomas. Acta Otolaryngol 120: 891–898.
31.
Hallmann, R., N. Horn, M. Selg, O. Wendler, F. Pausch, L.M. Sorokin (2005) Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85: 979–1000.
32.
Hampton, S. (2004) A small study in healing rates and symptom control using a new sheet hydrogel dressing. J Wound Care 13: 297–300.
33.
Hausman, G.J., J.T. Wright, R.L. Richardson (1996) The influence of extracellular matrix substrata on preadipocyte development in serum-free cultures of stromal-vascular cells. J Anim Sci 74: 2117–2128.
34.
Hausman, G.J., R.L. Richardson (2004) Adipose tissue angiogenesis. J Anim Sci 82: 925–934.
35.
Hendrix, M.J., E.A. Seftor, R.E. Seftor, I.J. Fidler (1987) A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 38: 137–147.
36.
Hemmrich, K., D. von Heimburg, R. Rendchen, C. Di Bartolo, E. Milella, N. Pallua (2005) Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 26: 7025–7037.
37.
Hemmrich, K., M. Meersch, U. Wiesemann, J. Salber, D. Klee, T. Gries, N. Pallua (2006) Polyesteramide-derived nonwovens as innovative degradable matrices support preadipocyte adhesion, proliferation, and differentiation. Tissue Eng 12: 3557–3565.
38.
Hemmrich, K., G.P.L. Thomas, K.M. Abberton, E.W. Thompson, J.A. Rophael, A.J. Penington, W.A. Morrison (2007) MCP-1 and NO promote adipogenesis in a model that mimics obesity. Obesity 15: 2951–2957.
39.
Hoddle, J. (2002) Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng 8: 295–308.
40.
Hofer, S.O., G.M. Mitchell, A.J. Penington, W.A. Morrison, R. RomeoMeeuw, E. Keramidaris, J. Palmer, K.R. Knight (2005) The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber. Br J Plast Surg 58: 1104–1114.
41.
Hoffman, A.S. (2001) Hydrogels for biomedical applications. Ann NY Acad Sci 944: 62–73.
42.
Hong, S.R., Y.M. Lee, T. Akaike (2002) Evaluation of a galactose-carrying gelatin sponge for hepatocytes culture and transplantation. J Biomed Mater Res A 67: 733–741
43.
Jeong, B., K.M. Lee, A. Gutowska, Y.H. An (2002) Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. Biomacromolecules 3: 865–868.
44.
Kang, X., Y. Xie, D.A. Kniss (2005) Adipose tissue model using three-dimensional cultivation of preadipocytes seeded onto fibrous polymer scaffolds. Tissue Eng 11: 458–468.
45.
Kawaguchi, N., K. Toriyama, E. Nicodemou-Lena, K. Inou, S. Torii, Y. Kitagawa (1998) De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 95: 1062–1066.
46.
Kedeshian, P., M.D. Sternlicht, M. Nguyen, Z.M. Shao, S.H. Barsky (1998) Humatrix, a novel myoepithelial matrical gel with unique biochemical and biological properties. Cancer Lett 123: 215–226.
47.
Kimura, Y., M. Ozeki, T. Inamoto, Y. Tabata (2002) Time course of de novo adipogenesis in Matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng 8: 603–613.
48.
Kimura, Y., M. Ozeki, T. Inamoto, Y. Tabata (2003) Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24: 2513–2521.
49.
Kirker, K.R., Y. Luo, S.E. Morris, J. Shelby, G.D. Prestwich (2004) Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. J Burn Care Rehabil 25: 276–286.
50.
Kleinman, H.K., M.L. McGarvey, L.A. Liotta, P.G. Robey (1982) Isolation and characterization of type IV procollagen, laminin and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 24: 6188–6193.
51.
Kleinman, H.K., M.L. McGarvey, J.R. Hassell, V.L. Star, F.B. Cannon, G.W. Laurie, G.R. Martin (1986) Basement membrane complexes with biological activity. Biochemistry 25: 312–318.
52.
Kleinman, H.K., G.R. Martin (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378–386.
53.
Kuo, C.K., P.X. Ma (2001) Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering. Part 1. Structure, gelation rate and mechanical properties. Biomaterials 2: 511–521.
54.
Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
55.
Lokmic, Z., F. Stillaert, W.A. Morrison, E.W. Thompson, G.M. Mitchell (2007) An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue engineered construct. FASEB J 21: 511–522.
56.
Liu, Y., X.Z. Shu, S.D. Gray, G.D. Prestwich (2004) Disulfide-crosslinked hyaluronan-gelatin sponge: growth of fibrous tissue in vivo. J Biomed Mater Res A 68: 142–149.
57.
Lutolf, M.P., J.L. Lauer-Fields, H.G. Schmoekel, A.T. Metters, F.E. Weber, G.B. Fields, J.A. Hubbell (2003) Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100: 5413–5418.
58.
Malinda, K.M., H.K. Kleinman (1996) The laminins. Int J Biochem Cell Biol 28: 957–959.
59.
Mann, B.K., J.L. West (2002) Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 60: 86–93.
60.
Marotta, M., G. Martino (1985) Sensitive spectrophotometric method for the quantitative estimation of collagen. Anal Biochem 150: 86–90.
61.
Marx, M., R.A. Perlmutter, J.A. Madri (1984) Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 93: 131–139.
62.
Messina, A., S.K. Bortolotto, O.C. Cassell, J. Kelly, K.M. Abberton, W.A. Morrison (2005) Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J 19: 1570–1572.
63.
Mian, R., W.A. Morrison, J.V. Hurley, A.J. Penington, R. Romeo, Y. Tanaka, K.R. Knight (2000) Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng 6: 595–603.
64.
Navarro, X., F.J. Rodriguez, D. Ceballos, E. Verdu (2003) Engineering an artificial nerve graft for the repair of severe nerve injuries. Med Biol Eng Comput 41: 220–226.
65.
Neubauer, M., C. Fischbach, P. Bauer-Kreisel, E. Lieb, M. Hacker, J. Tessmar, M.B. Schulz, A. Goepferich, T. Blunk (2004) Basic fibroblast growth factor enhances PPARγ ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 577: 277–283.
66.
Nicosia, R.F., A. Ottinetti (1990) Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in Matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 26: 119–128.
67.
Niimi, T., C. Kumagai, M. Okano, Y. Kitagawa (1997) Differentiation-dependent expression of laminin-8 (α4β1γ1) mRNAs in mouse 3T3-L1 adipocytes. Matrix Biol 16: 223–230.
68.
Peer, L. (1956) The neglected free fat graft. Am J Surg 18: 233–250.
69.
Powell, C.A., B.L. Smiley, J. Mills, H.H. Vandenburgh (2002) Mechanical stimulation improves tissue-engineered human skeletal muscle. Am J Physiol Cell Physiol 283: C1557–C1565.
70.
Pratt, A.B., F.E. Weber, H.G. Schmoekel, R. Muller, J.A. Hubbell (2004) Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng 86: 27–36.
71.
Rossatti, B. (1960) Revascularisation and phagocytosis in free fat autografts: an experimental study. Br J Plast Surg 13: 35–41.
72.
Rosso, F., A. Giordano, M. Barbarisi, A. Barbarisi (2004) From cell-ECM interactions to tissue engineering. J Cell Physiol 199: 174–180.
73.
Schmedlen, R.H., K.S. Masters, J.L. West (2002) Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. Biomaterials 23: 4325–4332.
74.
Siegal, G.P., M.H. Wang, C.A. Rinehart Jr., J.W. Kennedy, L.J. Goodly, Y. Miller, D.G. Kaufman, R.K. Singh (1993) Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett 69: 123–132.
75.
Smahel, J. (1986) Adipose tissue in plastic surgery. Ann Plast Surg 16: 444–453.
76.
Smith, P.J., L.S. Wise, R. Berkowitz, C. Wan, C.S. Rubin (1988) Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263: 9402–9408.
77.
Stark, H.J., M.J. Willhauck, N. Mirancea, K. Boehnke, I. Nord, D. Breitkreutz, Pavesio A., Boukamp P., Fusenig N.E. (2004) Authentic fibroblast matrix in dermal equivalents normalizes epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Eur J Cell Biol 83: 631–645.
78.
Stillaert, F., M. Findlay, J. Palmer, R. Idrizi, S. Cheang, A. Messina, K. Abberton, W. Morrison, E.W. Thompson (2007) Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber. Tissue Eng 13: 2291–2300.
79.
Tabata, Y. (2000) The importance of drug delivery systems in tissue engineering. Pharm Sci Technol Today 3: 80–89.
80.
Tabata, Y. (2004) Tissue regeneration based on tissue engineering technology. Congenital Anomalies 44: 111–124.
81.
Talts, J.F., Z. Andac, W. Gohring, A. Brancaccio, R. Timpl (1999) Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J 18: 863–870.
82.
Talts, J.F., T. Sasaki, N. Miosge, W. Gohring, K. Mann, R. Mayne, R. Timpl (2000) Structural and functional analysis of the recombinant g domain of the laminin α4 chain and its proteolytic processing in tissues. J Biol Chem 275: 35192–35199.
83.
Tartare-Deckert, S., C. Chavey, M.N. Monthouel, N. Gautier, E. Van Obberghen (2001) The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 276: 22231–22237.
84.
Thomas, G.P., K. Hemmrich, K.M. Abberton, D. McCombe, A.J. Penington, E.W. Thompson, W.A. Morrison (2007) Zymosan-induced inflammation stimulates neo-adipogenesis. Int J Obes (Lond) [E-pub ahead of print].
85.
Toti, P., M. Villanova, C. De Felice, T. Megha, S. Bartolommei, P. Tosi (1998) Expression of laminin 1 and 2 in brain tumor vessels: an immunohistochemical study. J Submicrosc Cytol Pathol 30: 227–230.
86.
Vashi, A.V., K.M. Abberton, G.P. Thomas, W.A. Morrison, A.J. O’Connor, J.J. Cooper-White, E.W. Thompson (2006) Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng 12: 3035–3043.
87.
Veronese, F.M., C. Mammucari, F. Schiavon, O. Schiavon, S. Lora, F. Secundo, A. Chilin, A. Guiotto (2001) Pegylated enzyme entrapped in poly(vinyl alcohol) hydrogel for biocatalytic application. Farmaco 56: 541–547.
88.
von Heimburg, D., M. Kuberka, R. Rendchen, K. Hemmrich, G. Rau, N. Pallua (2003) Preadipocyte-loaded collagen scaffolds with enlarged pore size for improved soft tissue engineering. Int J Artif Organs 26: 1064–1076.
89.
Wang, L., R.M. Shelton, P.R. Cooper, M. Lawson, J.T. Triffitt, J.E. Barralet (2003) Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials 24: 3475–3481.
90.
Wu, X., Black L., G. Santacana-Laffitte, C.W. Patrick Jr. (2007) Preparation and assessment of glutaraldehyde-crosslinked collagen-chitosan hydrogels for adipose tissue engineering. J Biomed Mater Res A 81: 59–65.
91.
Zhang, Y, H.K. Lin, D. Frimberger, R.B. Epstein, B.P. Kropp (2005) Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int 96: 1120–1125.
92.
Zuk, P.A., M. Zhu, H. Mizuno, J. Juang, J.W. Futrell, A.J. Katz, P. Benhaim, H.P. Lorenz, M.H. Hedrick (2001) Multilineage cells from human adipose tissue: implications for cell- based therapies. Tissue Eng 7: 211–228.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.